These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11286311)

  • 1. Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes. A panel discussion with audience participation.
    Chesebro JH; Verheugt FW; Kontny F; Fry ET; Wallentin L; Camm AJ; Bechtold H
    Clin Cardiol; 2001 Mar; 24(3 Suppl):I20-2. PubMed ID: 11286311
    [No Abstract]   [Full Text] [Related]  

  • 2. Head-to-head comparison of two different low-molecular-weight heparins in acute coronary syndrome: a single center experience.
    Ozdemir M; Erdem G; Türkoglu S; Cemri M; Timurkaynak T; Boyaci B; Ridvan Y; Cengel A; Dörtlemez O; Dörtlemez H
    Jpn Heart J; 2002 Sep; 43(5):433-42. PubMed ID: 12452301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low molecular weight heparin in acute coronary syndromes.
    Cannon CP
    Curr Cardiol Rep; 1999 Sep; 1(3):206-11. PubMed ID: 10980843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC).
    Klein W; Buchwald A; Hillis SE; Monrad S; Sanz G; Turpie AG; van der Meer J; Olaisson E; Undeland S; Ludwig K
    Circulation; 1997 Jul; 96(1):61-8. PubMed ID: 9236418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low molecular weight heparin in the treatment of acute coronary syndromes without ST-segment elevation: unstable angina and non-Q-wave myocardial infarction].
    Borja J; Olivella P
    Med Clin (Barc); 2000 Nov; 115(15):583-6. PubMed ID: 11141394
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulants in acute coronary syndromes.
    Turpie AG
    Am J Cardiol; 1999 Sep; 84(5A):2M-6M. PubMed ID: 10505536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparins: their established role in acute coronary syndromes and perspectives in atrial fibrillation.
    Melandri G; Nanni S; Tricoci P; Melloni C; Semprini F; Fallani F; Bracchetti G; Branzi A
    Haematologica; 2001 Nov; 86(11 Suppl 2):54-7. PubMed ID: 11926779
    [No Abstract]   [Full Text] [Related]  

  • 8. Low molecular weight heparin in acute coronary syndrome: evidence for superior or equivalent efficacy compared with unfractionated heparin?
    Kaul S; Shah PK
    J Am Coll Cardiol; 2000 Jun; 35(7):1699-712. PubMed ID: 10841215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-thrombotic therapy for elderly patients with acute coronary syndromes.
    Chen YT; Tuohy ER; Krumholz HM
    Coron Artery Dis; 2000 Jun; 11(4):323-30. PubMed ID: 10860175
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulants in coronary artery disease.
    Lee LV
    Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular weight heparins.
    Talley JD
    J Ark Med Soc; 1997 Apr; 93(11):555-6. PubMed ID: 9114648
    [No Abstract]   [Full Text] [Related]  

  • 12. [Low molecular weight heparin in unstable angina].
    Kher A; Samama MM
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1495-500. PubMed ID: 9092409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease.
    Klein W; Buchwald A; Hillis WS; Monrad S; Sanz G; Turpie AG; van der Meer J; Olaisson E; Undeland S; Ludwig K
    Am J Cardiol; 1997 Sep; 80(5A):30E-34E. PubMed ID: 9296467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of low-molecular-weight heparins in the management of patients with unstable angina pectoris and non-Q-wave acute myocardial infarction.
    Monrad ES
    Am J Cardiol; 2000 Apr; 85(8A):2C-9C. PubMed ID: 10793174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving outcomes in acute coronary syndromes--the FRISC II trial.
    Kontny F
    Clin Cardiol; 2001 Mar; 24(3 Suppl):I3-7. PubMed ID: 11286312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of low-molecular-weight heparin trials in cardiology.
    Shulman RI
    Pharmacol Ther; 2000 Jul; 87(1):1-9. PubMed ID: 10924738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparins in acute coronary syndrome.
    Creekmore F
    S D J Med; 2000 Jan; 53(1):21-3. PubMed ID: 10652862
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of low-molecular-weight heparin in acute coronary syndromes.
    Fiorini DM
    AACN Clin Issues; 2001 Feb; 12(1):53-61. PubMed ID: 11288329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic therapy in unstable angina/non-ST elevation myocardial infarction: the evolving role of low-molecular-weight heparin.
    Antman EM; Kereiakes DJ
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E1-4;discussion E25-8. PubMed ID: 11156721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of low-molecular-weight heparins in the treatment of acute coronary syndrome].
    Carlsson J; Tebbe U
    Dtsch Med Wochenschr; 2002 Apr; 127(16):859-65. PubMed ID: 11961704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.